Skip to main content

Study M363

Study name

Cano M 2017

Title

Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study

Overall design

The aim of this study was to assess longitudinal changes in (i) regional gray matter (GM) volumes and (ii) hippocampal metabolite concentrations throughout an acute course of bitemporal electroconvulsive therapy (ECT), as well as (iii) to determine the association between imaging changes and clinical improvement. Patients with treatment-resistant depression (TRD) (depression group, n = 12) were assessed at four time points (pre-treatment, after the first ECT session, after the ninth ECT session and 15 days after ECT course completion) and healthy participants (control group, n = 10) at two time points, 5 weeks apart. Metabolite quantification was reported relative to total creatine as the reference peak.

Study Type

Type1;

Type2;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Treatment-resistant depression; Treatment-resistant depression;

Criteria for depression

DSM-IV-TR diagnosed MDD

Sample size

22

Tissue

Central; Brain; Hippocampus;

Platform

MRS; MRS: Philips Achieva 3.0 Tesla magnet scanner (Philips Healthcare, Best, The Netherlands);

PMID

28170003

DOI

10.1038/tp.2016.267

Citation

Cano M, Martínez-Zalacain I, Bernabeu-Sanz A, et al. Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study. Transl Psychiatry 2017;7(2):e1023.

Metabolite

N-Acetyl aspartate/(Creatine and Phosphocreatine) ratio;